LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery
- PMID: 16624689
- DOI: 10.1016/j.cardfail.2005.10.012
LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery
Abstract
Background: With improved technology, increasing clinical experience, and expanding indications for use, left ventricular assist devices (LVADs) are assuming a greater role in the care of patients with end-stage heart failure. Early in the course of LVAD use as a bridge to transplant, it became evident that some patients exhibit substantial recovery of ventricular function, which led to the concept of reverse remodeling.
Methods and results: Herein we summarize and integrate insights derived from a multitude of studies that have investigated how LVAD support influences ventricular structural, cellular, extracellular matrix, molecular, biochemical, and metabolic characteristics of the end-stage failing heart. The focus includes a review of the extent and sustainability of reverse remodeling, the important advances in understanding of the pathophysiology of heart failure derived from these studies and the implications of these findings for development of new therapeutic strategies.
Conclusion: In brief, studies of LVAD-heart interactions have led to the understanding that although we once considered the end-stage failing heart of patients near death to be irreversibly diseased, when given sufficient mechanical unloading and restoration of more normal neurohormonal milieu, a relatively large degree of myocardial recovery is possible. Comparison of effects on right and left ventricles have provided mechanistic insights by implicating hemodynamic unloading as primarily regulating certain aspects of reverse remodeling, neurohormonal factors as regulating other aspects, and joint regulation of still other aspects. As such these observations have driven a shift of thinking of chronic heart failure as a progressive irreversible disease process to a potentially treatable entity.
Similar articles
-
Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.Prog Biophys Mol Biol. 2008 Jun-Jul;97(2-3):479-96. doi: 10.1016/j.pbiomolbio.2008.02.002. Epub 2008 Feb 12. Prog Biophys Mol Biol. 2008. PMID: 18394685 Review.
-
Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.Cardiovasc Res. 2005 Dec 1;68(3):376-86. doi: 10.1016/j.cardiores.2005.06.030. Epub 2005 Jul 18. Cardiovasc Res. 2005. PMID: 16024006 Review.
-
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.J Am Coll Cardiol. 2005 Mar 1;45(5):668-76. doi: 10.1016/j.jacc.2004.11.042. J Am Coll Cardiol. 2005. PMID: 15734609
-
Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments.J Card Fail. 2002 Dec;8(6 Suppl):S500-5. doi: 10.1054/jcaf.2002.129264. J Card Fail. 2002. PMID: 12555165 Review.
-
Biventricular assist device-induced right ventricular reverse structural and functional remodeling.J Heart Lung Transplant. 2005 Sep;24(9):1195-201. doi: 10.1016/j.healun.2004.08.005. J Heart Lung Transplant. 2005. PMID: 16143233
Cited by
-
Effects of the HeartMate II left ventricular assist device as observed by serial echocardiography.Echocardiography. 2013 May;30(5):513-20. doi: 10.1111/echo.12100. Epub 2013 Jan 11. Echocardiography. 2013. PMID: 23311405 Free PMC article.
-
Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy.J Am Heart Assoc. 2013 Apr 8;2(2):e000016. doi: 10.1161/JAHA.113.000016. J Am Heart Assoc. 2013. PMID: 23568341 Free PMC article.
-
Echocardiographic imaging and ventricular mechanics in pulsatile-flow LVAD pediatric patients: a systematic approach.Front Pediatr. 2024 Jan 29;12:1345891. doi: 10.3389/fped.2024.1345891. eCollection 2024. Front Pediatr. 2024. PMID: 38348212 Free PMC article. Review.
-
Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.J Heart Lung Transplant. 2007 Nov;26(11):1170-6. doi: 10.1016/j.healun.2007.08.003. J Heart Lung Transplant. 2007. PMID: 18022084 Free PMC article. Clinical Trial.
-
Bovine model of doxorubicin-induced cardiomyopathy.J Biomed Biotechnol. 2011;2011:758736. doi: 10.1155/2011/758736. Epub 2010 Dec 30. J Biomed Biotechnol. 2011. PMID: 21253525 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials